Taiwan FDA registration 7860ece305fe82ddb2ce5b4769f6b8ef
OMRON blood glucose monitoring system - Anjie
TW: 歐姆龍血糖監測系統-安捷
Taiwan·Risk Class 2·DELBIO INC.·Registered Jun 03, 2013 – Jun 03, 2018CancelledRegistration details
- Analysis ID
- 7860ece305fe82ddb2ce5b4769f6b8ef
Company information
- Manufacturer
- DELBIO INC.
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- DELBIO INC.
Product details
- Intended Use
- This product is used with the second generation of Omron blood glucose test tablets to quantitatively detect the blood glucose value of fingertip and palm microvascular whole blood, and is not suitable for neonatal testing.
- Product Type (Level 1)
- A Clinical Chemistry and Clinical Toxicology;; I General, Plastic Surgery and Dermatology
- Product Type (Level 2)
- I.4800 Manual instruments for general surgery; A.1345 Glucose Test System
- Import Information
- Domestic
Dates and status
- Registration Date
- Jun 03, 2013
- Expiry Date
- Jun 03, 2018
- Cancellation Date
- Dec 13, 2019
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for OMRON blood glucose monitoring system - Anjie in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 7860ece305fe82ddb2ce5b4769f6b8ef and manufactured by DELBIO INC.. The authorized representative in Taiwan is DELBIO INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices